---
title: "lenvatinib - Follicular thyroid carcinoma"
sidebar: mydoc_sidebar
permalink: lenvatinibfollicularthyroidcarcinoma3.html
toc: false 
---

{% include image.html file="lenvatinibfollicularthyroidcarcinoma3.png" alt="lenvatinibfollicularthyroidcarcinoma3" %}![Path Visualization](/images/lenvatinibfollicularthyroidcarcinoma3.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C531958 | lenvatinib | Drug |
| UniProt:P16234 | platelet-derived growth factor receptor (PDGFR) alpha | Protein |
| GO:0009987 | cellular processes | BiologicalProcess |
| CL:0001064 | cancer cell | Cell |
| MESH:D018263 | Follicular thyroid carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lenvatinib | DECREASES ACTIVITY OF | Platelet-Derived Growth Factor Receptor (Pdgfr) Alpha |
| Platelet-Derived Growth Factor Receptor (Pdgfr) Alpha | DISRUPTS | Cellular Processes |
| Cellular Processes | LOCATED IN | Cancer Cell |
| Cancer Cell | PARTICIPATES IN | Follicular Thyroid Carcinoma |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB09078#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB09078#mechanism-of-action){:target="_blank"}